ArticleOncoimmunology2021

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in

Michael G White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.